Select Guide Rating

• 1. Pyrexia of unknown origin: the use of PET and PET-CT ; 2. Neurological Complications of Lyme Borreliosis (LB) ; 3. Leptospirosis and its Complications ; 4. Secondary Syphilis ; 5. HIV-Associated Multicentric Castleman's Disease ; 6. HIV: Prevention of Mother to Child Transmission ; 7. HIV: Antiretroviral Treatment and Emergence of Resistance ; 8. HIV: opportunistic infections and immune reconstitution syndrome ; 9. HIV: Cryptococcal Meningitis and Timing of Antiretroviral Treatment ; 10. Candida Infection in the Intensive Care Unit ; 11. Disseminated Aspergillosis after Bone Marrow Transplantation ; 12. Hepatitis B Reactivation in the Immunosuppressed ; 13. Developments in the Treatment of Hepatitis C Virus Infection ; 14. Management of Viral Haemorrhagic Fevers in the UK ; 15. Tropical Liver Abscess: Diagnosis and Management ; 16. Severe Falciparum Malaria: Treatment Options in the UK ; 17. Imported Plasmodium Vivax ; 18. Typhoid Fever: Antibiotic Treatment Choices ; 19. Hospital Acquired Legionella Pneumonia ; 20. Severe Clostridium Difficile Infection (CDI) ; 21. Staphylococcal Prosthetic Joint Infection ; 22. Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteraemia ; 23. Pneumococcal Meningitis: Antibiotic Options for Resistant Organisms ; 24. Urinary Sepsis: Vancomycin-Resistant Enterococci (VRE) ; 25. Disseminated Nocardiosis ; 26. Urinary Sepsis: Extended Spectrum Beta Lactamase Producing (ESBL) E. coli ; 27. Multi-Drug Resistant Pseudomonas Aeruginosa Infection in Cystic Fibrosis ; 28. The Treatment of Mycobacterium Abscessus Lung Disease ; 29. Multi-Drug Resistant Tuberculosis ; 30. Diagnostic and Management Issues in Tuberculous Meningitis ; 31. Treated Pulmonary Tuberculous Complicated by Sarcoidosis

Select Guide Rating

• 1. Pyrexia of unknown origin: the use of PET and PET-CT ; 2. Neurological Complications of Lyme Borreliosis (LB) ; 3. Leptospirosis and its Complications ; 4. Secondary Syphilis ; 5. HIV-Associated Multicentric Castleman's Disease ; 6. HIV: Prevention of Mother to Child Transmission ; 7. HIV: Antiretroviral Treatment and Emergence of Resistance ; 8. HIV: opportunistic infections and immune reconstitution syndrome ; 9. HIV: Cryptococcal Meningitis and Timing of Antiretroviral Treatment ; 10. Candida Infection in the Intensive Care Unit ; 11. Disseminated Aspergillosis after Bone Marrow Transplantation ; 12. Hepatitis B Reactivation in the Immunosuppressed ; 13. Developments in the Treatment of Hepatitis C Virus Infection ; 14. Management of Viral Haemorrhagic Fevers in the UK ; 15. Tropical Liver Abscess: Diagnosis and Management ; 16. Severe Falciparum Malaria: Treatment Options in the UK ; 17. Imported Plasmodium Vivax ; 18. Typhoid Fever: Antibiotic Treatment Choices ; 19. Hospital Acquired Legionella Pneumonia ; 20. Severe Clostridium Difficile Infection (CDI) ; 21. Staphylococcal Prosthetic Joint Infection ; 22. Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteraemia ; 23. Pneumococcal Meningitis: Antibiotic Options for Resistant Organisms ; 24. Urinary Sepsis: Vancomycin-Resistant Enterococci (VRE) ; 25. Disseminated Nocardiosis ; 26. Urinary Sepsis: Extended Spectrum Beta Lactamase Producing (ESBL) E. coli ; 27. Multi-Drug Resistant Pseudomonas Aeruginosa Infection in Cystic Fibrosis ; 28. The Treatment of Mycobacterium Abscessus Lung Disease ; 29. Multi-Drug Resistant Tuberculosis ; 30. Diagnostic and Management Issues in Tuberculous Meningitis ; 31. Treated Pulmonary Tuberculous Complicated by Sarcoidosis

Select Guide Rating

• 1. Pyrexia of unknown origin: the use of PET and PET-CT ; 2. Neurological Complications of Lyme Borreliosis (LB) ; 3. Leptospirosis and its Complications ; 4. Secondary Syphilis ; 5. HIV-Associated Multicentric Castleman's Disease ; 6. HIV: Prevention of Mother to Child Transmission ; 7. HIV: Antiretroviral Treatment and Emergence of Resistance ; 8. HIV: opportunistic infections and immune reconstitution syndrome ; 9. HIV: Cryptococcal Meningitis and Timing of Antiretroviral Treatment ; 10. Candida Infection in the Intensive Care Unit ; 11. Disseminated Aspergillosis after Bone Marrow Transplantation ; 12. Hepatitis B Reactivation in the Immunosuppressed ; 13. Developments in the Treatment of Hepatitis C Virus Infection ; 14. Management of Viral Haemorrhagic Fevers in the UK ; 15. Tropical Liver Abscess: Diagnosis and Management ; 16. Severe Falciparum Malaria: Treatment Options in the UK ; 17. Imported Plasmodium Vivax ; 18. Typhoid Fever: Antibiotic Treatment Choices ; 19. Hospital Acquired Legionella Pneumonia ; 20. Severe Clostridium Difficile Infection (CDI) ; 21. Staphylococcal Prosthetic Joint Infection ; 22. Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteraemia ; 23. Pneumococcal Meningitis: Antibiotic Options for Resistant Organisms ; 24. Urinary Sepsis: Vancomycin-Resistant Enterococci (VRE) ; 25. Disseminated Nocardiosis ; 26. Urinary Sepsis: Extended Spectrum Beta Lactamase Producing (ESBL) E. coli ; 27. Multi-Drug Resistant Pseudomonas Aeruginosa Infection in Cystic Fibrosis ; 28. The Treatment of Mycobacterium Abscessus Lung Disease ; 29. Multi-Drug Resistant Tuberculosis ; 30. Diagnostic and Management Issues in Tuberculous Meningitis ; 31. Treated Pulmonary Tuberculous Complicated by Sarcoidosis